BYRON OSTEO LIMITEDActive

Company number 06934834Private limited companyIncorporated 2009

Key figures

£41,411+266.8%
Net assets 2024/25
+45.1%
Average annual growth 2019/20–2024/25
020 k40 k60 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, BYRON OSTEO LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets59,17719,47132,16741,03569,285
Total liabilities56,63919,16632,05729,74527,874
Net assets / total equity2,53830511011,29041,411
Average number of employees45566

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company during the year under review was osteopathy.

As described in the company's latest filed accounts.

Summary: BYRON OSTEO LIMITED

Company

BYRON OSTEO LIMITED is a private limited company registered with Companies House under company number 06934834. It was incorporated on 16 Jun 2009. Its status is active. The registered office is in London (NW8). Its nature of business (SIC 2007) is other service activities n.e.c. (96090).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £41,411, up 266.8% on the previous year. Total assets were £69,285 and total liabilities £27,874. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 30 Jun 2027.